Suppr超能文献

草药提取物对C57BL/6小鼠实验性自身免疫性脑脊髓炎的治疗作用

Healing Influence of Herbal Extract on Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice.

作者信息

Hassani Mahdieh, Soleimani Maryam, Esmaeilzadeh Emran, Zare-Abdollahi Davood, Khorram Khorshid Hamid Reza

机构信息

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Department of Basic Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

出版信息

Iran J Pharm Res. 2020 Fall;19(4):321-329. doi: 10.22037/ijpr.2020.113808.14505.

Abstract

The present study was designed to primarily examine the therapeutic potential of the herbal extract of for the treatment of multiple sclerosis in the experimental autoimmune encephalomyelitis (EAE) model of the disease. The animal model was induced in C57BL/6 female mice, and then the herbal extract was intraperitoneally administered for a total of 21 days after the first day of post-immunization. The phenotypic signs, a gene expression profile of inflammatory cytokines, antioxidant state, and pathological hallmarks of the disease in the corpus callosum were evaluated. The prophylactic administration of attenuates the clinical signs of the disease. It significantly declined the gene expression of pro-inflammatory cytokines like IL-6, TNF-α, and IFN-γ. This herbal extract also surged the gene expression, as an anti-inflammatory cytokine. The gene expression of Glutathione peroxidase and Catalase (antioxidant enzymes) was meaningfully higher in the treatment group. Pathological evaluation of corpus callosum cross-sections by Luxol Fast Blue staining revealed preserved myelin sheath in the treated group compared to the EAE mice. The results of our assay confirmed that immunomodulatory and antioxidant features of the herbal extract of ameliorated the EAE severity. This study finding disclosed the therapeutic efficiency of this compound in MS treatment.

摘要

本研究旨在主要考察[草药名称]的草药提取物在实验性自身免疫性脑脊髓炎(EAE)疾病模型中治疗多发性硬化症的潜力。在C57BL/6雌性小鼠中诱导建立动物模型,然后在免疫后第一天起腹腔注射该草药提取物,共注射21天。评估了疾病的表型体征、炎性细胞因子的基因表达谱、抗氧化状态以及胼胝体中的疾病病理特征。[草药名称]的预防性给药减轻了疾病的临床症状。它显著降低了促炎细胞因子如IL-6、TNF-α和IFN-γ的基因表达。这种草药提取物还增加了作为抗炎细胞因子的基因表达。治疗组中谷胱甘肽过氧化物酶和过氧化氢酶(抗氧化酶)的基因表达明显更高。通过Luxol Fast Blue染色对胼胝体横截面进行病理评估发现,与EAE小鼠相比,治疗组的髓鞘得以保留。我们的检测结果证实,[草药名称]的草药提取物的免疫调节和抗氧化特性改善了EAE的严重程度。本研究结果揭示了该化合物在多发性硬化症治疗中的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abd3/8019886/e78881fa8eec/ijpr-19-321-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验